The EU may unconditionally approve novo-nordisk a/s's acquisition of catalent.
The European Commission may unconditionally approve novo-nordisk a/s's parent company, Novo Holdings, to acquire the usa contract pharmaceutical company catalent for 16.5 billion USD.
The Trader: Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop -- Barron's
Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC
BMO Capital Maintains Novo-Nordisk A/S(NVO.US) With Buy Rating, Maintains Target Price $156
Smart Money Is Betting Big In NVO Options
Unusual Options Activity: LRCX, COIN and Others Attract Market Bets, LRCX V/OI Ratio Reaches 119.0
PrayHardToEarnMoney : boss bring me fly
Chris gogo : Wise enough, I will try to buy at 99 if possible![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")